Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Index
RUT
Market Cap
989.67M
Enterprise Value
876.37M
Income
-45.09M
Sales
192.44M
Book/sh
8.59
Cash/sh
7.75
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
738
IPO
Jan 31, 2005
P/E
-
Forward P/E
-
PEG
-
P/S
5.14
P/B
2.27
P/C
2.52
P/FCF
-
EV/EBITDA
-
EV/Sales
4.55
Quick Ratio
1.94
Current Ratio
2.04
Debt/Eq
0.48
LT Debt/Eq
0.08
Option/Short
Yes / Yes
EPS (ttm)
-0.90
EPS next Y
-0.67
EPS next Q
-0.17
EPS this Y
-161.67%
EPS next Y
22.39%
EPS next 5Y
-
EPS past 3/5Y
-0.23% 13.68%
Sales past 3/5Y
-9.45% 17.49%
EPS Y/Y TTM
21.02%
Sales Y/Y TTM
1.15%
EPS Q/Q
-47.16%
Sales Q/Q
13.54%
Insider Own
4.39%
Insider Trans
-13.28%
Inst Own
89.35%
Inst Trans
2.45%
ROA
-4.86%
ROE
-7.44%
ROIC
-7.08%
Gross Margin
40.16%
Oper. Margin
-20.02%
Profit Margin
-23.43%
SMA20
5.41%
SMA50
10.96%
SMA200
41.34%
Trades
Shs Outstand
50.69M
Shs Float
48.47M
52W High
21.78 -10.38%
52W Low
7.61 156.50%
Volatility
5.21% 5.71%
ATR (14)
1.04
RSI (14)
57.96
Beta
1.82
Rel Volume
0.01
Avg Volume
842.57K
Volume
231
Perf Week
-5.88%
Perf Month
14.96%
Perf Quarter
19.68%
Perf Half Y
49.81%
Perf YTD
103.33%
Perf Year
129.38%
Perf 3Y
43.32%
Perf 5Y
-73.36%
Perf 10Y
665.49%
Prev Close
19.80
Price
19.52
Change %
-1.41%
Consensus
Strong Buy
Avg. Price Target
$22.33
Implied Upside
+14.4%
Analysts12incl. previous ratings
Rating Distribution9 Buy · 3 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Aug 06, 2025Upgrade
LLeerink Partners
Market Perform → Outperform$16-18.0%
Aug 06, 2025Upgrade
KEY logoKKeyBanc Capital Markets
Sector Weight → Overweight
Jul 22, 2025Resumed
SStephens
Overweight$13-33.4%
Mar 24, 2025Upgrade
UBS logoUUBS
Neutral → Buy$10-48.8%
Dec 19, 2024Initiated
GGuggenheim
Buy$11-43.6%
Aug 07, 2024Downgrade
JEF logoJJefferies
Buy → Hold$20 → $8-59.0%
Jul 31, 2024Upgrade
RILY logoRB. Riley Securities
Neutral → Buy$19 → $15-23.2%
May 03, 2024Downgrade
RILY logoRB. Riley Securities
Buy → Neutral$22 → $19-2.7%
Apr 04, 2024Resumed
JEF logoJJefferies
Buy$17 → $21+7.6%
Mar 13, 2024Reiterated
NNeedham
Buy$19 → $18-7.8%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sawicki Mark WChief Scientific OfficerNov 10 '26Sale19.9310,000199,26192,356Nov 12 06:30 PM
HANCOCK DANIEL MDirectorNov 09 '26Option Exercise9.9174,379737,192143,431Nov 12 06:27 PM
HANCOCK DANIEL MDirectorNov 09 '26Sale20.2174,3791,502,97669,052Nov 12 06:27 PM
MARK SAWICKIOfficerNov 10 '26Proposed Sale19.9310,000199,261Nov 10 05:13 PM
DANIEL M HANCOCKDirectorNov 09 '26Proposed Sale19.1074,3791,420,639Nov 09 04:30 PM
SHELTON JERRELLPresident, CEOAug 11 '26Sale14.9128,800429,3851,201,814Aug 11 06:49 PM
JERRELL W SHELTONDirectorAug 11 '26Proposed Sale14.8228,800426,816Aug 11 04:31 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Option Exercise4.8033,600161,280143,319Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Option Exercise4.801,4006,720111,119Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Sale14.4733,600486,239109,719Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Sale15.231,40021,324109,719Jun 12 06:38 PM
EDWARD ZECCHINIOfficerJun 11 '26Proposed Sale14.4733,600486,239Jun 11 04:09 PM
EDWARD ZECCHINIOfficerJun 10 '26Proposed Sale15.231,40021,324Jun 10 04:15 PM
STEFANOVICH ROBERTChief Financial OfficerJun 04 '26Sale16.27169,4272,756,984109,850Jun 08 09:11 PM
Mandalam RamkumarDirectorJun 08 '26Sale15.4423,214358,45267,894Jun 08 09:05 PM
RAMKUMAR MANDALAMDirectorJun 08 '26Proposed Sale15.4423,214358,452Jun 08 04:17 PM
STEFANOVICH ROBERTOfficerJun 04 '26Proposed Sale16.50169,4272,795,546Jun 03 04:35 PM
SHELTON JERRELLPresident, CEOApr 21 '26Option Exercise1.87104,007194,4931,230,614Apr 23 08:00 PM
SHELTON JERRELLPresident, CEOApr 06 '26Option Exercise1.8750,00093,5001,126,607Apr 08 06:32 PM
STEFANOVICH ROBERTChief Financial OfficerMar 23 '26Sale8.181,0948,949279,277Mar 25 08:01 PM
SHELTON JERRELLPresident, CEOMar 23 '26Option Exercise1.8725,00046,7501,076,607Mar 25 08:00 PM
SHELTON JERRELLPresident, CEOMar 23 '26Sale8.182,89423,6731,051,607Mar 25 08:00 PM
Sawicki Mark WChief Scientific OfficerMar 23 '26Sale8.181,34110,969102,356Mar 25 08:00 PM
ZECCHINI EDWARD JSee RemarksMar 16 '26Sale8.002,01416,112109,719Mar 17 08:01 PM
SHELTON JERRELLPresident, CEOMar 16 '26Sale8.007,91863,3441,054,501Mar 17 08:00 PM
Sawicki Mark WChief Scientific OfficerMar 16 '26Sale8.003,23525,880103,697Mar 17 08:00 PM
STEFANOVICH ROBERTChief Financial OfficerMar 12 '26Option Exercise1.8787,188163,042294,401Mar 16 09:35 PM
STEFANOVICH ROBERTChief Financial OfficerMar 12 '26Sale7.7638,700300,386255,701Mar 16 09:35 PM
STEFANOVICH ROBERTChief Financial OfficerMar 16 '26Sale8.002,74321,944280,371Mar 16 09:35 PM
ROBERT S. STEFANOVICHOfficerMar 12 '26Proposed Sale7.7638,700300,386Mar 12 04:17 PM
Mandalam RamkumarDirectorDec 10 '25Sale9.9911,570115,54080,758Dec 12 05:30 PM
RAMKUMAR MANDALAMDirectorDec 10 '25Proposed Sale9.9911,570115,540Dec 10 04:10 PM
Cryoport, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
ChairmanMr. Jerrell W. Shelton
Senior VPMr. Robert S. Stefanovich MS
Senior VP and Chief Digital & Technology OfficerMr. Edward J. Zecchini
Senior VP & Chief Scientific OfficerDr. Mark W. Sawicki Ph.D.
Chief Operating OfficerMr. Chris LaGullo